Jayakumar J, Ginjupalli M, Kalaivani Babu A, Rajarajan S, Jakkam Setty M
Cureus. 2025; 16(12):e75822.
PMID: 39816323
PMC: 11735017.
DOI: 10.7759/cureus.75822.
Galstyan D, Lebedev A, Ilyin N, Papulova M, Golushko N, Tishkina V
Neurochem Res. 2024; 50(1):11.
PMID: 39549192
DOI: 10.1007/s11064-024-04268-9.
Jahn K, Blumer N, Wieltsch C, Duzzi L, Fuchs H, Meister R
Schizophrenia (Heidelb). 2024; 10(1):96.
PMID: 39448630
PMC: 11502758.
DOI: 10.1038/s41537-024-00498-6.
Basso V, Dobrossy M, Thompson L, Kirik D, Fuller H, Gates M
Biology (Basel). 2024; 13(9).
PMID: 39336117
PMC: 11428604.
DOI: 10.3390/biology13090690.
Correll C, Tusconi M, Carta M, Dursun S
Biomolecules. 2024; 14(8).
PMID: 39199294
PMC: 11353083.
DOI: 10.3390/biom14080906.
Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders.
Ijomone O, Oria R, Ijomone O, Aschner M, Bornhorst J
Mol Neurobiol. 2024; 62(2):2420-2434.
PMID: 39110391
PMC: 11772124.
DOI: 10.1007/s12035-024-04418-8.
Establishment of a Mitochondrial Metabolism-Related Diagnostic Model in Schizophrenia Based on LASSO Algorithm.
Liu Y, Lin H, Liu M, Lin L, Wen Y
Psychiatry Investig. 2024; 21(6):618-628.
PMID: 38960439
PMC: 11222072.
DOI: 10.30773/pi.2024.0011.
The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders.
Palmisano A, Pandit S, Smeralda C, Demchenko I, Rossi S, Battelli L
Life (Basel). 2024; 14(5).
PMID: 38792599
PMC: 11122172.
DOI: 10.3390/life14050578.
Bridging cholinergic signalling and inflammation in schizophrenia.
Metz C, Brines M, Pavlov V
Schizophrenia (Heidelb). 2024; 10(1):51.
PMID: 38734678
PMC: 11088617.
DOI: 10.1038/s41537-024-00472-2.
Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia.
Sahay S, Devine E, McCullumsmith R, ODonovan S
Cells. 2024; 13(1).
PMID: 38201235
PMC: 10778287.
DOI: 10.3390/cells13010032.
Psychiatric adverse reactions to non-selective RET multi-kinase inhibitors: a large-scale pharmacovigilance analysis.
Wang X, Yin D, Tang Y, Xiao F, Wang S
Front Pharmacol. 2023; 14:1209933.
PMID: 37465525
PMC: 10351039.
DOI: 10.3389/fphar.2023.1209933.
BDNF and Cognitive Function in Chilean Schizophrenic Patients.
Nieto R, Silva H, Armijo A, Nachar R, Gonzalez A, Castaneda C
Int J Mol Sci. 2023; 24(13).
PMID: 37445746
PMC: 10341589.
DOI: 10.3390/ijms241310569.
Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies.
Kositsyn Y, de Abreu M, Kolesnikova T, Lagunin A, Poroikov V, Harutyunyan H
Int J Mol Sci. 2023; 24(11).
PMID: 37298431
PMC: 10253480.
DOI: 10.3390/ijms24119482.
Positive allosteric adenosine A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice.
Lin Y, Roy K, Ioka S, Otani R, Amezawa M, Ishikawa Y
Front Pharmacol. 2023; 14:1138666.
PMID: 37153764
PMC: 10155833.
DOI: 10.3389/fphar.2023.1138666.
Widespread RNA hypoediting in schizophrenia and its relevance to mitochondrial function.
Choudhury M, Fu T, Amoah K, Jun H, Chan T, Park S
Sci Adv. 2023; 9(14):eade9997.
PMID: 37027465
PMC: 10081846.
DOI: 10.1126/sciadv.ade9997.
GluN2D Subunit in Parvalbumin Interneurons Regulates Prefrontal Cortex Feedforward Inhibitory Circuit and Molecular Networks Relevant to Schizophrenia.
Gawande D, S Narasimhan K, Shelkar G, Pavuluri R, Stessman H, Dravid S
Biol Psychiatry. 2023; 94(4):297-309.
PMID: 37004850
PMC: 10524289.
DOI: 10.1016/j.biopsych.2023.03.020.
Elucidation of the mechanisms underlying tumor aggravation by the activation of stress-related neurons in the paraventricular nucleus of the hypothalamus.
Yoshida S, Hamada Y, Narita M, Sato D, Tanaka K, Mori T
Mol Brain. 2023; 16(1):18.
PMID: 36732798
PMC: 9896675.
DOI: 10.1186/s13041-023-01006-0.
Methylation pattern and mRNA expression of synapse-relevant genes in the MAM model of schizophrenia in the time-course of adolescence.
Khan A, Thielen L, Le Pen G, Krebs M, Kebir O, Groh A
Schizophrenia (Heidelb). 2022; 8(1):110.
PMID: 36481661
PMC: 9732294.
DOI: 10.1038/s41537-022-00319-8.
Crossroad between current knowledge and new perspective of diagnostic and therapy of late-onset schizophrenia and very late-onset schizophrenia-like psychosis: An update.
Stpien-Wyrobiec O, Nowak M, Wyrobiec G, Morawiec E, Wierzbik-Stronska M, Staszkiewicz R
Front Psychiatry. 2022; 13:1025414.
PMID: 36387009
PMC: 9643586.
DOI: 10.3389/fpsyt.2022.1025414.
ICAM-Reg: Interpretable Classification and Regression With Feature Attribution for Mapping Neurological Phenotypes in Individual Scans.
Bass C, Da Silva M, Sudre C, Williams L, Sousa H, Tudosiu P
IEEE Trans Med Imaging. 2022; 42(4):959-970.
PMID: 36374873
PMC: 10315989.
DOI: 10.1109/TMI.2022.3221890.